— Know what they know.
Not Investment Advice

ISEE NASDAQ

IVERIC bio, Inc.
1W: +1.6% 1M: +3.0% 3M: +47.6% 1Y: +257.0% 3Y: +702.2% 5Y: +1337.0%
$39.95
Last traded 2023-07-10 — delisted
NASDAQ · Healthcare · Biotechnology · $5.5B mcap · 137M float · 3.86% daily turnover

Balance Sheet Trends

Total Assets
$667M +71.3% ▲
5Y CAGR: +30.6%
Total Liabilities
$132M +358.4% ▲
5Y CAGR: -0.8%
Shareholders Equity
$535M +48.3% ▲
5Y CAGR: +69.7%
Cash & Investments
$647M +69.4% ▲
5Y CAGR: +31.1%
Total Debt
$98M +6123.3% ▲
Net Debt
-$379M -45.7% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2022
— Assets —
Cash$131M$126M$66M$261M$476M
Short-Term Investments$0$0$144M$120M$171M
Cash & ST Investments$131M$126M$210M$382M$647M
Net Receivables$4M$882K$2M$0$0
Inventory-$4M$0-$2M$0$0
Other Current Assets$2M$2M$7M$6M$16M
Total Current Assets$133M$129M$217M$387M$663M
Property, Plant & Equip.$335K$669K$146K$2M$2M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$4M$894K$5K$0$2M
Total Non-Current Assets$4M$2M$151K$2M$4M
Total Assets$137M$130M$217M$389M$667M
— Liabilities —
Accounts Payable$6M$6M$13M$13M$23M
Short-Term Debt$0$495K$54K$952K$1M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$7M$7M$12M$14M$12M
Total Current Liabilities$13M$13M$25M$28M$36M
Long-Term Debt$0$0$61K$619K$97M
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$0$61K$619K$97M
Total Liabilities$13M$13M$25M$29M$132M
— Equity —
Common Stock$41K$50K$90K$115K$137K
Retained Earnings-$422M-$481M-$565M-$680M-$865M
Accumulated OCI-$422M$0$3K-$90K-$229K
Total Stockholders Equity$124M$117M$191M$361M$535M
Total Liabilities & Equity$137M$130M$217M$389M$667M
— Key Metrics —
Total Debt$0$495K$115K$2M$98M
Net Debt-$131M-$125M-$66M-$260M-$379M
Total Investments$0$0$144M$120M$171M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms